GENERATIXE
Live / Applied — First extension granted (statement of use) (as of 16 Aug 2025)
What this means for you
Not registered yet, but its 27 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98522751
- Mark type
- Stylized text
- Filed
- 27 Apr 2024
- Published for opposition
- 10 Dec 2024
Goods and services
- Class 042 — Scientific and technological services: Biochemical research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Circular RNA vaccine research; Gene therapy research; Pharmaceutical research and development; Pharmaceutical research services; RNA interference technology research; Scientific research; Scientific research and development
Owner
- Generatixe Inc., Austin, TX, US
- Generatixe Inc., Austin, TX, US
Prosecution history
- 17 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Aug 2025 — SOU EXTENSION 1 GRANTED
- 16 Aug 2025 — SOU EXTENSION 1 FILED
- 16 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 27 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Apr 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 02 Jan 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Nov 2024 — ASSIGNED TO EXAMINER
- 20 Oct 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Apr 2024 — NEW APPLICATION ENTERED